Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.516NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.526NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.279NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.51NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.18NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XATNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.85NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.65NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BG.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.74NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.62NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.8NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.13.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.28NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XAZNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.24NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.1.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.26NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.290NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.341NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.161NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.69 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.46NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.139NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.508NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.94NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.463NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.357NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.318NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.557NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.119NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.160NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
D.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.447NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.110.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used